Pricing and marketing efficiencies will drive only 1 per cent to incremental growth rate of the Indian pharma market in 2015, says a a white paper titled ‘CII-Interlink Paper on Growth Agenda of pharmaceutical industry in India’.
Interlink, a business and management consulting firm in the pharmaceuticals and healthcare industry, has developed an income consumption model to forecast growth of pharmaceutical industry by 2015 by quantifying market growth of six specific growth drivers.
These include middle class population, health insurance facilities, unpenetrated markets, marketing efficiencies, generics and brand development.
These drivers taken together will contribute 6.64 per cent of market growth.
The pharmaceutical market is estimated to grow at 19.64 per cent by 2015.
